BMJ  2005;330:1222-1223 (28 May), doi:10.1136/bmj.330.7502.1222

Editorial

Next steps in trial registration

Minimum criteria have been agreed, and intentions restated

The first 150 words of the full text of this article appear below.

Last year medical journals responded to the growing clamour for greater transparency in the conduct of clinical trials by deciding to require registration of trials that are submitted for publication.¹ Various groups have proposed criteria to clarify the implementation of this policy.^{2 3} These moves have received a mostly positive response from the public, regulators, and industry. Associations of pharmaceutical companies have signalled their support for registration of trials and recording of results although, regrettably, registration will only be voluntary.⁴ Individual pharmaceutical companies have announced their own initiatives, albeit under pressure from lawmakers and the needs of the market. ⁵

Now the International Committee of Medical Journal Editors (ICMJE) has announced further guidance on trial registration.⁶ In essence, the guidance restates that trials that begin enrolling patients from 1 July 2005 must be registered in a public trials registry—at or before the onset of enrolment—to be considered for publication in the journals . . . [Full text of this article]

kabbasi@bmj.com

fgodlee@bmj.com BMJ, London WC1H 9JR

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Winning hearts and minds

Fiona Godlee
BMJ 2005 330: 0. [Extract] [Full Text] [PDF]

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1)

Karmela Krleza-Jeric, An-Wen Chan, Kay Dickersin, Ida Sim, Jeremy Grimshaw, Christian Gluud for the Ottawa Group
BMJ 2005 330: 956-958. [Extract] [Full Text] [PDF]

More on compulsory registration of clinical trials: GSK has created useful register

Ronald Krall and Frank Rockhold
BMJ 2005 330: 479-480. [Extract] [Full Text]

Drug companies agree to make clinical trial results public

Susan Mayor
BMJ 2005 330: 109. [Extract] [Full Text] [PDF]

Compulsory registration of clinical trials

Kamran Abbasi
BMJ 2004 329: 637-638. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Wager, E. (2005). A concern that drug companies cannot ignore. JRSM 98: 448-450 [Full text]  

Rapid Responses:

Read all Rapid Responses

Registration of clinical trials

Peter C Arnold
bmj.com, 21 Jun 2005 [Full text]

Online poll

Find out more >>